Humana Inc (HUM) Stake Lessened by First Citizens Bank & Trust Co.

First Citizens Bank & Trust Co. lowered its stake in shares of Humana Inc (NYSE:HUM) by 34.6% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,134 shares of the insurance provider’s stock after selling 4,304 shares during the period. First Citizens Bank & Trust Co.’s holdings in Humana were worth $2,017,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently added to or reduced their stakes in the company. Prudential Financial Inc. raised its position in shares of Humana by 53.6% during the third quarter. Prudential Financial Inc. now owns 378,133 shares of the insurance provider’s stock valued at $92,125,000 after buying an additional 131,990 shares during the last quarter. Parametric Portfolio Associates LLC raised its position in shares of Humana by 11.9% during the third quarter. Parametric Portfolio Associates LLC now owns 451,212 shares of the insurance provider’s stock valued at $109,929,000 after buying an additional 47,987 shares during the last quarter. AXA raised its position in shares of Humana by 24.2% during the third quarter. AXA now owns 34,900 shares of the insurance provider’s stock valued at $8,503,000 after buying an additional 6,800 shares during the last quarter. Public Employees Retirement System of Ohio raised its position in shares of Humana by 2.4% during the third quarter. Public Employees Retirement System of Ohio now owns 98,701 shares of the insurance provider’s stock valued at $24,047,000 after buying an additional 2,348 shares during the last quarter. Finally, GSA Capital Partners LLP raised its position in shares of Humana by 159.3% during the third quarter. GSA Capital Partners LLP now owns 10,111 shares of the insurance provider’s stock valued at $2,463,000 after buying an additional 6,211 shares during the last quarter. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Humana Inc (NYSE:HUM) opened at $263.10 on Thursday. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.61 and a current ratio of 1.61. Humana Inc has a 1 year low of $186.25 and a 1 year high of $264.90. The firm has a market cap of $37,470.00, a price-to-earnings ratio of 20.72, a price-to-earnings-growth ratio of 1.74 and a beta of 0.88.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, November 8th. The insurance provider reported $3.39 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.27 by $0.12. Humana had a net margin of 3.49% and a return on equity of 15.99%. The business had revenue of $13.28 billion for the quarter, compared to analysts’ expectations of $13.41 billion. During the same quarter in the previous year, the business posted $3.18 earnings per share. The business’s revenue was down 3.0% compared to the same quarter last year. equities research analysts expect that Humana Inc will post 11.63 EPS for the current fiscal year.

Humana declared that its board has authorized a share buyback plan on Thursday, December 14th that permits the company to buyback $3.00 billion in outstanding shares. This buyback authorization permits the insurance provider to buy shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s leadership believes its stock is undervalued.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Shareholders of record on Friday, December 29th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 0.61%. The ex-dividend date is Thursday, December 28th. Humana’s dividend payout ratio (DPR) is 12.60%.

In other Humana news, VP Timothy S. Huval sold 1,382 shares of the business’s stock in a transaction on Tuesday, December 19th. The shares were sold at an average price of $246.04, for a total transaction of $340,027.28. Following the transaction, the vice president now owns 11,557 shares in the company, valued at $2,843,484.28. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Brian P. Leclaire sold 1,679 shares of the business’s stock in a transaction on Thursday, December 21st. The shares were sold at an average price of $245.97, for a total transaction of $412,983.63. Following the transaction, the senior vice president now owns 9,888 shares in the company, valued at approximately $2,432,151.36. The disclosure for this sale can be found here. Insiders have sold 10,115 shares of company stock worth $2,501,627 in the last quarter. Company insiders own 0.80% of the company’s stock.

HUM has been the topic of several research reports. Credit Suisse Group reduced their price target on shares of Humana from $256.00 to $246.00 and set a “neutral” rating on the stock in a research report on Friday, November 10th. ValuEngine cut shares of Humana from a “buy” rating to a “hold” rating in a research report on Tuesday, December 19th. BMO Capital Markets initiated coverage on shares of Humana in a research report on Monday, October 16th. They issued an “outperform” rating and a $300.00 price target on the stock. Goldman Sachs Group initiated coverage on shares of Humana in a research report on Wednesday, January 3rd. They issued a “buy” rating and a $305.00 price target on the stock. Finally, Zacks Investment Research cut shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 17th. Eleven analysts have rated the stock with a hold rating and twelve have given a buy rating to the company. The company presently has an average rating of “Buy” and an average target price of $260.70.

COPYRIGHT VIOLATION NOTICE: This piece was posted by Community Financial News and is owned by of Community Financial News. If you are reading this piece on another website, it was stolen and republished in violation of United States & international copyright legislation. The legal version of this piece can be accessed at https://www.com-unik.info/2018/01/11/humana-inc-hum-stake-lessened-by-first-citizens-bank-trust-co.html.

About Humana

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group and Specialty, Healthcare Services and Individual Commercial. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc (NYSE:HUM).

Institutional Ownership by Quarter for Humana (NYSE:HUM)

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit